These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21883881)

  • 1. Fondaparinux in acute heparin-induced thrombocytopenia: a case series.
    Goldfarb MJ; Blostein MD
    J Thromb Haemost; 2011 Dec; 9(12):2501-3. PubMed ID: 21883881
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogenic but effective: the HIT-fondaparinux brain puzzler.
    Greinacher A
    J Thromb Haemost; 2011 Dec; 9(12):2386-8. PubMed ID: 21929685
    [No Abstract]   [Full Text] [Related]  

  • 3. Heparin-induced thrombocytopenia in the ICU: an overview.
    Sakr Y
    Crit Care; 2011; 15(2):211. PubMed ID: 21457505
    [No Abstract]   [Full Text] [Related]  

  • 4. Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series.
    Warkentin TE; Pai M; Sheppard JI; Schulman S; Spyropoulos AC; Eikelboom JW
    J Thromb Haemost; 2011 Dec; 9(12):2389-96. PubMed ID: 21883878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful treatment with fondaparinux in heparin-induced thrombocytopenia and thrombosis].
    Seculini Patiño CE; Pascualini MF; Tabares AH
    Medicina (B Aires); 2015; 75(5):307-10. PubMed ID: 26502466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overtreatment of Heparin-Induced Thrombocytopenia in the Surgical ICU.
    Harada MY; Hoang DM; Zaw AA; Murry JS; Volod O; Sun BJ; Nuño M; Mason R; Margulies DR; Ley EJ
    Crit Care Med; 2017 Jan; 45(1):28-34. PubMed ID: 27513533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fondaparinux as a treatment option for heparin-induced thrombocytopenia.
    Papadopoulos S; Flynn JD; Lewis DA
    Pharmacotherapy; 2007 Jun; 27(6):921-6. PubMed ID: 17542773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Fondaparinux in Patients With Suspected Heparin-Induced Thrombocytopenia.
    Snodgrass MN; Shields J; Rai H
    Clin Appl Thromb Hemost; 2016 Nov; 22(8):712-717. PubMed ID: 27179015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic considerations in the management of patients with heparin-induced thrombocytopenia.
    Tong LM; Mendez MN
    Prog Cardiovasc Nurs; 2002; 17(3):142-7. PubMed ID: 12091763
    [No Abstract]   [Full Text] [Related]  

  • 10. How we manage patients with heparin induced thrombocytopenia.
    Scully M; Gates C; Neave L
    Br J Haematol; 2016 Jul; 174(1):9-15. PubMed ID: 27097741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II.
    Wellborn-Kim JJ; Mitchell GA; Terneus WF; Stowe CL; Malias MA; Sparkman GM; Hanson GW
    Am J Health Syst Pharm; 2010 Jul; 67(13):1075-9. PubMed ID: 20554593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of fondaparinux in a patient with antiphospholipid antibody syndrome and heparin-associated thrombocytopenia.
    Holtan SG; Knox SK; Tefferi A
    J Thromb Haemost; 2006 Jul; 4(7):1632-4. PubMed ID: 16839370
    [No Abstract]   [Full Text] [Related]  

  • 13. Fondaparinux (Arixtra(R)), a safe alternative for the treatment of patients with heparin-induced thrombocytopenia?
    Badger NO
    J Pharm Pract; 2010 Jun; 23(3):235-8. PubMed ID: 21507819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fondaparinux treatment in heparin induced thrombocytopenia:a case report].
    Ozsu S; Korkmaz A; Bülbül Y; Oztuna F; Ozlü T
    Tuberk Toraks; 2011; 59(2):178-83. PubMed ID: 21740395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of unsuccessful treatment of heparin-induced thrombocytopenia (HIT) with fondaparinux.
    Miranda AC; Donovan JL; Tran MT; Gore JM
    J Thromb Thrombolysis; 2012 Jan; 33(1):133-5. PubMed ID: 21947717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New concepts in heparin-induced thrombocytopenia: diagnosis and management.
    Spinler SA
    J Thromb Thrombolysis; 2006 Feb; 21(1):17-21. PubMed ID: 16475037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fondaparinux in a critically Ill patient with heparin-induced thrombocytopenia: A case report.
    He Y; He H; Liu D; Long Y; Su L; Cheng W
    Medicine (Baltimore); 2018 Sep; 97(37):e12236. PubMed ID: 30212955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia.
    Lobo B; Finch C; Howard A; Minhas S
    Thromb Haemost; 2008 Jan; 99(1):208-14. PubMed ID: 18217156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective evaluation of fondaparinux for confirmed or suspected heparin-induced thrombocytopenia in left-ventricular-assist device patients.
    Benken ST; Tillman N; Dajani S; Shah A; Thomas T
    J Cardiothorac Surg; 2014 Mar; 9():55. PubMed ID: 24656312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study.
    Kang M; Alahmadi M; Sawh S; Kovacs MJ; Lazo-Langner A
    Blood; 2015 Feb; 125(6):924-9. PubMed ID: 25515959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.